THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Roche and Nurix Therapeutics — BTK degrader collaboration
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Roche and Nurix Therapeutics will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- Basel, Switzerland
- Source checked
- September 27, 2026
FOLLOW THE STORY